No abstract available
MeSH terms
-
Adenocarcinoma / blood
-
Adenocarcinoma / diagnostic imaging
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / secondary*
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biopsy
-
Carcinoma, Neuroendocrine / blood
-
Carcinoma, Neuroendocrine / diagnostic imaging
-
Carcinoma, Neuroendocrine / drug therapy
-
Carcinoma, Neuroendocrine / secondary*
-
Cell Differentiation
-
Disease Progression
-
Endoscopy, Gastrointestinal
-
Fatal Outcome
-
Humans
-
Immunohistochemistry
-
Liver Neoplasms / blood
-
Liver Neoplasms / diagnostic imaging
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / secondary*
-
Magnetic Resonance Imaging
-
Male
-
Pancreatic Neoplasms / blood
-
Pancreatic Neoplasms / diagnostic imaging
-
Pancreatic Neoplasms / drug therapy
-
Pancreatic Neoplasms / pathology*
-
Stomach Neoplasms
-
Time Factors
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
Tumor Burden
-
Ultrasonography
-
alpha-Fetoproteins / analysis*
Substances
-
AFP protein, human
-
alpha-Fetoproteins